Home | All trials

[RDF data]
Trial NCT00000107

Resource URI: http://static.linkedct.org/resource/trials/NCT00000107
linkedct:brief_title Body Water Content in Cyanotic Congenital Heart Disease
linkedct:condition <http://static.linkedct.org/resource/condition/5698>
linkedct:criteria Inclusion Criteria: - Resting blood pressure below 140/90
linkedct:download_date Information obtained from ClinicalTrials.gov on December 30, 2009
linkedct:eligibility_gender Both
linkedct:eligibility_healthy_volunteers Accepts Healthy Volunteers
linkedct:eligibility_maximum_age 60 Years
linkedct:eligibility_minimum_age 17 Years
linkedct:enrollment 0 (xsd:int)
linkedct:firstreceived_date January 18, 2000
linkedct:id NCT00000107
rdfs:label Trial NCT00000107
linkedct:lastchanged_date June 23, 2005
linkedct:lead_sponsor_agency National Center for Research Resources (NCRR)
linkedct:location <http://static.linkedct.org/resource/location/149543>
linkedct:nct_id NCT00000107
linkedct:number_of_arms 0 (xsd:int)
linkedct:number_of_groups 0 (xsd:int)
linkedct:org_study_id NCRR-M01RR00109-0737
linkedct:overall_status Completed
linkedct:oversight <http://static.linkedct.org/resource/oversight/2918>
foaf:page <http://clinicaltrials.gov/show/NCT00000107>
linkedct:phase N/A
linkedct:secondary_id M01RR00109
linkedct:source National Center for Research Resources (NCRR)
linkedct:study_design Natural History, Case Control
linkedct:study_type Observational
linkedct:summary Adults with cyanotic congenital heart disease have elevated levels of plasma proatrial natruretic peptide (proANP) which most likely results in chronic dehydration, leading to reduced oxygen transport to tissues and shortness of breath with activity. The purpose of this study is to characterize adults with cyanotic congenital heart defects with respect to their body composition (water and fat-free mass) and resting metabolic rates. The study consists of several measures of how much body water, fat and lean tissue a subject has, and measures the number of calories the subject's body uses at rest. Adult subjects with cyanotic congenital heart disease will be recruited along with healthy noncyanotic control subjects matched for age, gender, and body weight.
rdf:type linkedct:trials
linkedct:verification_date December 2003